KOPRAN
Back to Income Statement
|
KOPRAN Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹615 Cr | ₹551 Cr | ₹478 Cr | ₹492 Cr | ₹359 Cr |
What is the latest Revenue of KOPRAN ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹615 Cr |
| Mar2024 | ₹551 Cr |
| Mar2023 | ₹478 Cr |
| Mar2022 | ₹492 Cr |
| Mar2021 | ₹359 Cr |
How is Revenue of KOPRAN Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹615 Cr | 11.54 | |
| Mar2024 | ₹551 Cr | 15.38 | |
| Mar2023 | ₹478 Cr | -2.91 | |
| Mar2022 | ₹492 Cr | 36.81 | |
| Mar2021 | ₹359 Cr | - | |
Compare Revenue of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹788.3 Cr | -1.1% | 1.5% | -9.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -1.1% |
1.5% |
-9.5% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses